BioCryst Pharmaceuticals, Inc. announced that on January 4, 2013, Robert S. Lowrey, the Controller and Principal Accounting Officer tendered his resignation from employment with the company, effective January 25, 2013. Beginning January 26, 2013, Mr. Thomas Staab, who has been the company's Chief Financial Officer since July 1, 2011, will serve as the company's Chief Financial and Principal Accounting Officer.